These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Apocynin Attenuates Cardiac Injury in Type 4 Cardiorenal Syndrome via Suppressing Cardiac Fibroblast Growth Factor-2 With Oxidative Stress Inhibition. Liu Y, Liu Y, Liu X, Chen J, Zhang K, Huang F, Wang JF, Tang W, Huang H. J Am Heart Assoc; 2015 Jun 24; 4(7):. PubMed ID: 26109504 [Abstract] [Full Text] [Related]
5. Interrelationship between renin-angiotensin-aldosterone system and oxidative stress in chronic heart failure patients with or without renal impairment. Reina-Couto M, Afonso J, Carvalho J, Morgado L, Ronchi FA, de Oliveira Leite AP, Dias CC, Casarini DE, Bettencourt P, Albino-Teixeira A, Morato M, Sousa T. Biomed Pharmacother; 2021 Jan 24; 133():110938. PubMed ID: 33171402 [Abstract] [Full Text] [Related]
6. [Cardio-renal interactions]. Ito S. Nihon Rinsho; 2012 Sep 24; 70(9):1562-70. PubMed ID: 23012804 [Abstract] [Full Text] [Related]
7. Pathogenesis and treatment of the cardiorenal syndrome: Implications of L-arginine-nitric oxide pathway impairment. Rajapakse NW, Nanayakkara S, Kaye DM. Pharmacol Ther; 2015 Oct 24; 154():1-12. PubMed ID: 25989232 [Abstract] [Full Text] [Related]
8. Kidney and heart interactions during cardiorenal syndrome: a molecular and clinical pathogenic framework. Napoli C, Casamassimi A, Crudele V, Infante T, Abbondanza C. Future Cardiol; 2011 Jul 24; 7(4):485-97. PubMed ID: 21797745 [Abstract] [Full Text] [Related]
9. Kidney Response to Heart Failure: Proteomic Analysis of Cardiorenal Syndrome. Melenovsky V, Cervenka L, Viklicky O, Franekova J, Havlenova T, Behounek M, Chmel M, Petrak J. Kidney Blood Press Res; 2018 Jul 24; 43(5):1437-1450. PubMed ID: 30235455 [Abstract] [Full Text] [Related]
10. Pathophysiology of cardiorenal syndrome type 2 in stable chronic heart failure: workgroup statements from the eleventh consensus conference of the Acute Dialysis Quality Initiative (ADQI). Cruz DN, Schmidt-Ott KM, Vescovo G, House AA, Kellum JA, Ronco C, McCullough PA. Contrib Nephrol; 2013 Jul 24; 182():117-36. PubMed ID: 23689659 [Abstract] [Full Text] [Related]
12. Qiliqiangxin Protects against Renal Injury in Rat with Cardiorenal Syndrome Type I through Regulating the Inflammatory and Oxidative Stress Signaling. Duan X, Yan F, Hu H, Liu H, Wu Q, Sun S, Ming X, Bu X, He Y, Zhu H. Biol Pharm Bull; 2018 Jul 24; 41(8):1178-1185. PubMed ID: 30068867 [Abstract] [Full Text] [Related]
14. Role and Mechanism of the Renin-Angiotensin-Aldosterone System in the Onset and Development of Cardiorenal Syndrome. Ma K, Gao W, Xu H, Liang W, Ma G. J Renin Angiotensin Aldosterone Syst; 2022 Jul 24; 2022():3239057. PubMed ID: 35111237 [Abstract] [Full Text] [Related]
15. N-Palmitoylethanolamide protects the kidney from hypertensive injury in spontaneously hypertensive rats via inhibition of oxidative stress. Mattace Raso G, Simeoli R, Russo R, Santoro A, Pirozzi C, d'Emmanuele di Villa Bianca R, Mitidieri E, Paciello O, Pagano TB, Orefice NS, Meli R, Calignano A. Pharmacol Res; 2013 Oct 24; 76():67-76. PubMed ID: 23917217 [Abstract] [Full Text] [Related]
16. Protective effects of naringenin in cardiorenal syndrome. Liu Y, An W, Gao A. J Surg Res; 2016 Jun 15; 203(2):416-23. PubMed ID: 27363651 [Abstract] [Full Text] [Related]
17. The role of the kidney in heart failure. Metra M, Cotter G, Gheorghiade M, Dei Cas L, Voors AA. Eur Heart J; 2012 Sep 15; 33(17):2135-42. PubMed ID: 22888113 [Abstract] [Full Text] [Related]
20. Oxidative stress and glomerular filtration barrier injury: role of the renin-angiotensin system in the Ren2 transgenic rat. Whaley-Connell AT, Chowdhury NA, Hayden MR, Stump CS, Habibi J, Wiedmeyer CE, Gallagher PE, Tallant EA, Cooper SA, Link CD, Ferrario C, Sowers JR. Am J Physiol Renal Physiol; 2006 Dec 15; 291(6):F1308-14. PubMed ID: 16788142 [Abstract] [Full Text] [Related] Page: [Next] [New Search]